Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease

Journal of Neuroscience Research
Hafiz Mohmmad AbdulD A Butterfield

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by loss of memory and cognition and by senile plaques and neurofibrillary tangles in brain. Amyloid-beta peptide, particularly the 42-amino-acid peptide (Abeta(1-42)), is a principal component of senile plaques and is thought to be central to the pathogenesis of the disease. The AD brain is under significant oxidative stress, and Abeta(1-42) peptide is known to cause oxidative stress in vitro and in vivo. Acetyl-L-carnitine (ALCAR) is an endogenous mitochondrial membrane compound that helps to maintain mitochondrial bioenergetics and lowers the increased oxidative stress associated with aging. Glutathione (GSH) is an important endogenous antioxidant, and its levels have been shown to decrease with aging. Administration of ALCAR increases cellular levels of GSH in rat astrocytes. In the current study, we investigated whether ALCAR plays a protective role in cortical neuronal cells against Abeta(1-42)-mediated oxidative stress and neurotoxicity. Decreased cell survival in neuronal cultures treated with Abeta(1-42) correlated with an increase in protein oxidation (protein carbonyl, 3-nitrotyrosine) and lipid peroxidation (4-hydroxy-2-nonenal) format...Continue Reading

References

Jan 1, 1988·Life Sciences·R G FarielloM DeMattei
Jan 1, 1994·Methods in Cell Biology·Z DarzynkiewiczJ Gong
Oct 29, 1993·Science·J T Coyle, P Puttfarcken
Sep 24, 1993·Annals of the New York Academy of Sciences·A CartaS N Bhuachalla
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D T LooC W Cotman
Feb 13, 1997·Biochemical and Biophysical Research Communications·H KuratsuneB Långström
Jan 1, 1997·Free Radical Biology & Medicine·W R Markesbery
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·T M HagenB N Ames
Dec 10, 1998·Nature Medicine·J L Platt, K A Nath
Feb 4, 1999·Journal of Neurochemistry·N Y CalingasanG E Gibson
Feb 13, 1999·The Journal of Biological Chemistry·M J WagstaffD S Latchman
Feb 22, 2000·The Journal of Biological Chemistry·A TakedaM A Smith
Mar 17, 2000·Free Radical Biology & Medicine·R Liu, J Choi
May 4, 2000·The American Journal of Pathology·Z DongA K Roy
Aug 6, 2000·Japanese Journal of Pharmacology·T IshiiK Kinoshita
Aug 15, 2000·Journal of Structural Biology·S VaradarajanD A Butterfield
Oct 29, 2000·Experimental Gerontology·H M Schipper
Mar 29, 2001·Physiological Reviews·D J Selkoe
Jun 14, 2001·Journal of the American Chemical Society·S VaradarajanD A Butterfield
Oct 10, 2001·Journal of Neuroscience Research·S AndoT Kawabata
Oct 30, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·M Pollack, C Leeuwenburgh
Dec 6, 2001·Trends in Molecular Medicine·D A ButterfieldA Castegna
Jun 6, 2003·Journal of Neurochemistry·Alessandra CastegnaD Allan Butterfield
Feb 28, 2004·The Journal of Biological Chemistry·Anatoliy KravetsMahin D Maines
Apr 13, 2004·Oncogene·Dick D Mosser, Richard I Morimoto
May 5, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·H Fai PoonD Allan Butterfield
Oct 13, 2004·Brain Research·Maria Alexandra BritoD Allan Butterfield

❮ Previous
Next ❯

Citations

Aug 18, 2009·Archives of Virology·Laura ColomboGianluigi Forloni
Jun 3, 2009·Apoptosis : an International Journal on Programmed Cell Death·Ying ZhangFlorian Lang
Apr 23, 2013·Cell Stress & Chaperones·Melinda Erzsébet TóthMiklós Sántha
May 28, 2011·Journal of Physiology and Biochemistry·Thangaraj AnnaduraiPitchairaj Geraldine
Jun 29, 2007·Expert Reviews in Molecular Medicine·Jean-Christophe Rochet
Jun 30, 2009·Antioxidants & Redox Signaling·Vittorio CalabreseD Allan Butterfield
Jul 9, 2009·Antioxidants & Redox Signaling·Francesco BelliaEnrico Rizzarelli
Jun 2, 2012·International Journal of Alzheimer's Disease·Joan Smith Sonneborn
May 13, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Jicheng LiuYingcai Niu
Jan 25, 2013·International Journal of Molecular Sciences·Shruti SharmaStephen M Black
Jun 2, 2011·International Journal of Alzheimer's Disease·Marjelo A MinesRichard S Jope
Apr 27, 2013·Immunity & Ageing : I & a·Carolin CorneliusVittorio Calabrese
Oct 9, 2008·Neurochemical Research·Rita SelvaticiAnna Siniscalchi
May 22, 2008·Expert Opinion on Investigational Drugs·Joanna K SoczynskaRoger S McIntyre
Nov 29, 2007·Expert Opinion on Investigational Drugs·Cesare MancusoVittorio Calabrese
Jun 4, 2011·Expert Opinion on Therapeutic Targets·Florian LangErich Gulbins
Sep 10, 2014·Frontiers in Aging Neuroscience·Debora CutuliLaura Petrosini
Sep 20, 2008·European Journal of Pharmacology·Roberta EpisMonica Di Luca
Jun 25, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·So-Young ParkDonggeun Sul
Feb 1, 2018·Pharmaceuticals·Rafaela PeronMárcia Regina Cominetti
Sep 26, 2006·Journal of Neuroscience Research·Cesare MancusoVittorio Calabrese
Feb 21, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jan P NicolayFlorian Lang
Sep 21, 2007·Nature Reviews. Neuroscience·Vittorio CalabreseAnna Maria Giuffrida Stella
May 19, 2009·BioFactors·Vittorio CalabreseEdward J Calabrese
Jan 18, 2018·Current Neuropharmacology·Ianara Mendonça da CostaFausto Pierdoná Guzen
Nov 26, 2013·Journal of Neuroscience Research·Ulrika BeitnereInga Kadish
Nov 20, 2019·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Christie A CostelloGuangju Zhai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.